Literature DB >> 10088200

Monounsaturated trans fatty acids, elaidic acid and trans-vaccenic acid, metabolism and incorporation in phospholipid molecular species in hepatocytes.

B Woldseth1, K Retterstøl, B O Christophersen.   

Abstract

The incorporation of [14C]elaidic acid (trans18:1(n-9)) in phosphatidylcholine and phosphatidylethanolamine molecular species in isolated rat liver cells has been studied, and the results compared with the incorporation, previously published (B. Woldseth et al. Biochim Biophys Acta 1993; 1167: 296-302), of [14C]palmitic acid (16:0) and [14C]stearic acid (18:0) and with that of [14C]oleic acid (cis18:1(n-9)). The pattern of incorporation in phospholipid molecular species is similar to that of [14C]stearic acid and different from that of [14C]palmitic acid. In phosphatidylcholine [14C]trans18:1-18:2 and [14C]trans18:1-20:4 were the most abundant species, and in phosphatidylethanolamine [14C]trans18:1-20:4 was the predominant species. With increasing concentration of [14C]elaidic acid increasing amounts of [14C]trans18:1-[14C]trans18:1 were found. The total incorporation in phospholipids was less than that of [14C]stearic acid, but more than that of [14C]palmitic acid. The distribution in percent of [14C]elaidic acid in phospholipid classes was 8.8% in phosphatidylinositol, 1.8% in phosphatidylserine, 59.1% in phosphatidylcholine and 30.3% in phosphatidylethanolamine with 0.1 mmol l-1 substrate concentration. More [14C]elaidic acid than [14C]palmitic acid or [14C]stearic acid was oxidized. The incorporation in phospholipids of [14C]elaidic acid was very different from that of [14C]oleic acid. The main species with [14C]oleic acid were 16:0-[14C]cis18:1 in phosphatidylcholine, and [14C]cis18:1-20:4 in phosphatidylethanolamine. In some experiments [14C]18:2(n-6) was incubated together with unlabelled elaidic or unlabelled trans-vaccenic acid (trans18:1(n-7)). In these experiments, more trans18:1-18:2 was formed from elaidic acid than from trans-vaccenic acid, especially in phosphatidylethanolamine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10088200     DOI: 10.1080/00365519850186067

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  5 in total

1.  Trans Fatty Acids Suppress TNF-α-Induced Inflammatory Gene Expression in Endothelial (HUVEC) and Hepatocellular Carcinoma (HepG2) Cells.

Authors:  Marine S Da Silva; Pierre Julien; Jean-François Bilodeau; Olivier Barbier; Iwona Rudkowska
Journal:  Lipids       Date:  2017-03-18       Impact factor: 1.880

2.  Vaccenic and elaidic acid equally esterify into triacylglycerols, but differently into phospholipids of fed rat liver cells.

Authors:  Zhen-Yu Du; Pascal Degrace; Joseph Gresti; Olivier Loreau; Pierre Clouet
Journal:  Lipids       Date:  2011-05-26       Impact factor: 1.880

3.  Effects of elaidic acid on lipid metabolism in HepG2 cells, investigated by an integrated approach of lipidomics, transcriptomics and proteomics.

Authors:  Lone Vendel Nielsen; Toke P Krogager; Clifford Young; Carla Ferreri; Chryssostomos Chatgilialoglu; Ole Nørregaard Jensen; Jan J Enghild
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

4.  Different Metabolism and Toxicity of TRANS Fatty Acids, Elaidate and Vaccenate Compared to Cis-Oleate in HepG2 Cells.

Authors:  Farkas Sarnyai; Éva Kereszturi; Kitti Szirmai; Judit Mátyási; Johanna Iman Al-Hag; Tamás Csizmadia; Péter Lőw; Péter Szelényi; Viola Tamási; Kinga Tibori; Veronika Zámbó; Blanka Tóth; Miklós Csala
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

5.  Effect of trans fatty acid intake on LC-MS and NMR plasma profiles.

Authors:  Gözde Gürdeniz; Daniela Rago; Nathalie Tommerup Bendsen; Francesco Savorani; Arne Astrup; Lars O Dragsted
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.